Drug-Induced Autoimmune Hepatitis From Hydralazine Leading to Acute Liver Failure and Liver Transplantation

Authors

Jasleen Grewal, University of California at Los Angeles
Angela Doan, University of California at Los Angeles
Annie S. Hong, University of Nevada, Las VegasFollow
Arpit Amin, University of California at Los Angeles
Jason V. Scapa, University of California at Los Angeles
Ramy Hanna, University of California at Los Angeles
Francisco Durazo, University of California at Los Angeles
Beshoy Yanny, University of California at Los Angeles

Document Type

Article

Publication Date

10-23-2019

Publication Title

American College of Gastroenterology

Volume

6

Issue

10

First page number:

1

Last page number:

4

Abstract

We describe a woman with no previous liver disease who developed drug-induced autoimmune hepatitis from hydralazine prescribed to her for hypertension. Despite the discontinuation of the medication, she developed acute liver failure and subsequently underwent successful liver transplantation. She survived and had a good clinical outcome.

Disciplines

Medical Sciences | Medicine and Health Sciences | Surgery

File Format

pdf

File Size

465 KB

Language

English

Creative Commons License

This work is licensed under a Creative Commons Attribution 4.0 License.

Repository Citation

Grewal, J., Doan, A., Hong, A. S., Amin, A., Scapa, J. V., Hanna, R., Durazo, F., Yanny, B. (2019). Drug-Induced Autoimmune Hepatitis From Hydralazine Leading to Acute Liver Failure and Liver Transplantation. American College of Gastroenterology, 6(10), 1-4.
http://dx.doi.org/10.14309/crj.0000000000000252